Two Sigma Advisers
PLX icon

Two Sigma Advisers’s Protalix BioTherapeutics PLX Stock Holding History

Two Sigma Advisers’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,900
Closed -$23.2K – 1590
2025
Q4 		$23.2K Buy
12,900
+2,600
+25% +$5.32K ﹤0.01% 2311
2025
Q3 		$22.9K Buy
+10,300
New +$16.8K ﹤0.01% 2295
2025
Q2 		– Sell
-33,015
Closed -$84.5K – 2486
2025
Q1 		$84.5K Buy
+33,015
New +$78.8K ﹤0.01% 2260
2023
Q2 		– Sell
-19,900
Closed -$41.8K – 2600
2023
Q1 		$41.8K Sell
19,900
-700
-3% -$1.23K ﹤0.01% 2467
2022
Q4 		$28.2K Sell
20,600
-4,700
-19% -$5.16K ﹤0.01% 2407
2022
Q3 		$26K Sell
25,300
-48,371
-66% -$53.6K ﹤0.01% 2429
2022
Q2 		$80K Buy
73,671
+14,771
+25% +$17.3K ﹤0.01% 2420
2022
Q1 		$62K Sell
58,900
-41,000
-41% -$37.6K ﹤0.01% 2563
2021
Q4 		$83K Buy
99,900
+85,700
+604% +$89.8K ﹤0.01% 2431
2021
Q3 		$19K Buy
+14,200
New +$21.6K ﹤0.01% 2404
2015
Q3 		– Sell
-1,030
Closed -$20K – 1938
2015
Q2 		$20K Buy
+1,030
New +$21.4K ﹤0.01% 1853
2013
Q4 		– Sell
-1,120
Closed -$50K – 2483
2013
Q3 		$50K Sell
1,120
-209
-16% -$10.7K ﹤0.01% 2042
2013
Q2 		$64K Buy
+1,329
New +$70.5K ﹤0.01% 2105

Other funds holding PLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Two Sigma Advisers's PLX Position: Q1 2026 in Review

Two Sigma Advisers sold out of Protalix BioTherapeutics (PLX) in Q1 2026, closing a stake of 12,900 shares — an estimated $23.2K sold.

Two Sigma Advisers first reported a position in PLX in Q2 2013 and held it in 13 quarters. The position peaked at $84.5K in Q1 2025. 99 funds tracked by Wall St. Rank hold PLX as of Q1 2026.

  • Two Sigma Advisers reported no remaining Protalix BioTherapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 12,900 Protalix BioTherapeutics shares in Q1 2026, an estimated $23.2K.
  • Two Sigma Advisers first reported a position in Protalix BioTherapeutics in Q2 2013 and held it in 13 quarters.
  • Two Sigma Advisers's Protalix BioTherapeutics position peaked at $84.5K in Q1 2025.
  • 99 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.